Snowball logo
logo
6881

Hunan Nucien Pharmaceutical Co Ltd

688189 SHG
¥6.40-¥0.10  (1.54%)
Estimate
EPS
-0.49
Beta
0.23
Growth
Revenue, YoY
41.35%
Net income, YoY
25.2%
FCF, YoY
-115.2%
About the company
Ticker
688189
ISIN
CNE100007713
Country
Other
Sector (GICS)
Healthcare
Hunan Nucien Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the research and development, production, and sale of chemical drugs in China. The company also focuses on the research, development, production, and sales of antiviral drugs, including influenza and infectious disease prevention and treatment drugs, as well as medicines for anti-influenza, malignant tumors, cardiovascular, antibiotics, antipyretics, pain relief, diabetes, analgesic, cerebrovascular, respiratory, and other pharmaceutical fields. Hunan Nucien Pharmaceutical Co., Ltd. was founded in 2006 and is based in Guangzhou, China.

Frequently asked questions

What sector does Hunan Nucien Pharmaceutical Co Ltd (688189) operate in?

Hunan Nucien Pharmaceutical Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Hunan Nucien Pharmaceutical Co Ltd (688189) current stock price?

As of the latest data, Hunan Nucien Pharmaceutical Co Ltd stock price is CN¥6.40, with a previous close of CN¥6.50. Hunan Nucien Pharmaceutical Co Ltd lost -CN¥0.10 in the last trading session, representing a -1.54% loss.

What is Hunan Nucien Pharmaceutical Co Ltd (688189) current market capitalization?

Hunan Nucien Pharmaceutical Co Ltd market cap is approximately 1.75 billion.

What is Hunan Nucien Pharmaceutical Co Ltd (688189) Earnings Per Share (EPS)?

The trailing EPS is -CN¥0.49.

Does Hunan Nucien Pharmaceutical Co Ltd (688189) pay dividends?

No. Hunan Nucien Pharmaceutical Co Ltd does not pay a dividend.

What is Hunan Nucien Pharmaceutical Co Ltd (688189) beta (volatility) score?

Hunan Nucien Pharmaceutical Co Ltd has a beta of 0.230, indicating lower volatility than the overall market.